Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXFO Inc and related companies with MarketBeat.com's FREE daily email newsletter.
Critical Analysis: EXFO (EXFO) and Mesa Laboratories (MLAB)
EXFO (NASDAQ: EXFO) and Mesa Laboratories (NASDAQ:MLAB) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitabiliy, earnings and institutional ownership.
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXFO Inc and related companies with MarketBeat.com's FREE daily email newsletter.
Risk & Volatility
EXFO has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Mesa Laboratories has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.
Dividends
Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.4%. EXFO does not pay a dividend. Mesa Laboratories pays out 22.0% of its earnings in the form of a dividend.
Analyst Ratings
This is a breakdown of current recommendations and price targets for EXFO and Mesa Laboratories, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| EXFO | 0 | 4 | 1 | 0 | 2.20 |
| Mesa Laboratories | 0 | 0 | 1 | 0 | 3.00 |
EXFO currently has a consensus target price of $5.70, indicating a potential upside of 31.03%. Given EXFO’s higher possible upside, equities analysts clearly believe EXFO is more favorable than Mesa Laboratories.
Profitability
This table compares EXFO and Mesa Laboratories’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| EXFO | 0.93% | 2.76% | 2.10% |
| Mesa Laboratories | 11.94% | 17.67% | 9.74% |
Insider & Institutional Ownership
16.8% of EXFO shares are held by institutional investors. Comparatively, 65.2% of Mesa Laboratories shares are held by institutional investors. 20.0% of EXFO shares are held by company insiders. Comparatively, 17.0% of Mesa Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares EXFO and Mesa Laboratories’ top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| EXFO | $243.18 million | 0.98 | $17.91 million | $0.04 | 108.78 |
| Mesa Laboratories | $93.67 million | 5.93 | $25.82 million | $2.91 | 51.10 |
Mesa Laboratories has higher revenue, but lower earnings than EXFO. Mesa Laboratories is trading at a lower price-to-earnings ratio than EXFO, indicating that it is currently the more affordable of the two stocks.
Summary
Mesa Laboratories beats EXFO on 9 of the 15 factors compared between the two stocks.
EXFO Company Profile
Mesa Laboratories Company Profile